HSBC Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by HSBC from $644.00 to $653.00 in a research report sent to investors on Monday,MarketScreener reports. HSBC currently has a buy rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the company. Rothschild & Co Redburn increased their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. UBS Group reaffirmed a “neutral” rating on shares of Intuitive Surgical in a report on Thursday, January 15th. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Leerink Partners raised their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Evercore ISI reduced their target price on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $618.52.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $528.81 on Monday. The firm has a market cap of $189.57 billion, a price-to-earnings ratio of 67.02, a PEG ratio of 4.26 and a beta of 1.67. Intuitive Surgical has a one year low of $425.00 and a one year high of $609.08. The firm has a 50 day simple moving average of $561.96 and a 200-day simple moving average of $511.58.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 earnings per share. Equities analysts predict that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, VP Fredrik Widman sold 2,067 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the sale, the vice president directly owned 473 shares in the company, valued at $260,150. The trade was a 81.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $496,455.52. The trade was a 83.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 48,152 shares of company stock valued at $27,470,571 in the last 90 days. Insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of ISRG. Riversedge Advisors LLC lifted its stake in Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after buying an additional 17 shares in the last quarter. Fiduciary Financial Group LLC increased its position in Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares in the last quarter. Prosperity Consulting Group LLC raised its holdings in shares of Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after acquiring an additional 19 shares during the last quarter. Rossmore Private Capital lifted its position in shares of Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after acquiring an additional 20 shares in the last quarter. Finally, Activest Wealth Management boosted its stake in shares of Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after acquiring an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.